295 related articles for article (PubMed ID: 1661259)
1. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation.
Miros M; Kerlin P; Walker N; Harper J; Lynch S; Strong R
Gut; 1991 Nov; 32(11):1369-73. PubMed ID: 1661259
[TBL] [Abstract][Full Text] [Related]
2. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
Martins EB; Fleming KA; Garrido MC; Hine KR; Chapman RW
Gastroenterology; 1994 Aug; 107(2):537-42. PubMed ID: 8039630
[TBL] [Abstract][Full Text] [Related]
3. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis.
Nichols JC; Gores GJ; LaRusso NF; Wiesner RH; Nagorney DM; Ritts RE
Mayo Clin Proc; 1993 Sep; 68(9):874-9. PubMed ID: 8396700
[TBL] [Abstract][Full Text] [Related]
6. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moff SL; Clark DP; Maitra A; Pandey A; Thuluvath PJ
J Clin Gastroenterol; 2006 Apr; 40(4):336-41. PubMed ID: 16633106
[TBL] [Abstract][Full Text] [Related]
7. Surgery for sclerosing cholangitis.
Braasch JW
Curr Opin Gen Surg; 1994; ():156-60. PubMed ID: 7583954
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.
Boberg KM; Jebsen P; Clausen OP; Aabakken L; Brekke I; Schrumpf E
J Hepatol; 2003 Sep; 39(3):453. PubMed ID: 12927935
[No Abstract] [Full Text] [Related]
9. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation.
Stieber AC; Marino IR; Iwatsuki S; Starzl TE
Int Surg; 1989; 74(1):1-3. PubMed ID: 2540107
[TBL] [Abstract][Full Text] [Related]
11. A Patient with Primary Sclerosing Cholangitis and Diffuse Biliary Dilation.
Fejleh MP; Yang SE; Kim S
Gastroenterology; 2021 Feb; 160(3):e17-e18. PubMed ID: 32598888
[No Abstract] [Full Text] [Related]
12. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: finding a needle in a haystack.
Navaneethan U
Endoscopy; 2016 May; 48(5):417-8. PubMed ID: 27115919
[No Abstract] [Full Text] [Related]
13. Intrahepatic segmental primary sclerosing cholangitis: report of a case.
Matsumoto T; Ajiki T; Matsumoto I; Tominaga M; Hori H; Mita Y; Fujita T; Fujino Y; Suzuki Y; Ku Y; Kuroda Y
Surg Today; 2006; 36(7):638-41. PubMed ID: 16794801
[TBL] [Abstract][Full Text] [Related]
14. Assessment for liver transplantation in patients with primary sclerosing cholangitis.
Broomé U; Eriksson LS
J Hepatol; 1994 May; 20(5):654-9. PubMed ID: 8071544
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
16. De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant.
Heneghan MA; Tuttle-Newhall JE; Suhocki PV; Muir AJ; Morse M; Bornstein JD; Sylvestre PB; Collins B; Kuo PC; Rockey DC
Am J Transplant; 2003 May; 3(5):634-8. PubMed ID: 12752322
[TBL] [Abstract][Full Text] [Related]
17. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
18. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
[TBL] [Abstract][Full Text] [Related]
19. Prevention of bile duct cancer in primary sclerosing cholangitis.
Harrison PM
Ann Oncol; 1999; 10 Suppl 4():208-11. PubMed ID: 10436824
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Bergquist A; Broomé U
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
